This is a synthetic peptide designed for use in combination with anti-DIRC2 antibody (Catalog #: ARP50133_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
限制
仅限研究用
状态
Lyophilized
溶解方式
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
浓度
1 mg/mL
缓冲液
Final peptide concentration is 1 mg/mL in PBS.
注意事项
Avoid repeated freeze-thaw cycles.
储存条件
-20 °C
储存方法
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
抗原
DIRC2
(Disrupted in Renal Carcinoma 2 (DIRC2))
别名
MGC80843 Peptide, zgc:92095 Peptide, rcc4 Peptide, MGC69320 Peptide, RCC4 Peptide, disrupted in renal carcinoma 2 Peptide, disrupted in renal carcinoma 2 L homeolog Peptide, disrupted in renal carcinoma 2 (human) Peptide, DIRC2 Peptide, dirc2.L Peptide, dirc2 Peptide, Dirc2 Peptide
背景
DIRC2 is a membrane-bound protein from the major facilitator superfamily of transporters. Disruption of DIRC2 by translocation has been associated with haplo-insufficiency and renal cell carcinomas. Alternatively spliced transcript variants have been described, but their biological validity has not yet been determined.This gene encodes a membrane-bound protein from the major facilitator superfamily of transporters. Disruption of this gene by translocation has been associated with haplo-insufficiency and renal cell carcinomas. Alternatively spliced transcript variants have been described, but their biological validity has not yet been determined. Sequence Note: The RefSeq transcript and protein were derived from genomic sequence and transcripts to make the sequence consistent with the reference genome assembly. The genomic coordinates used for the transcript record were based on alignments.